Health and Wellbeing · Men & Womens Health

23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome

 

By 23andMe on Tue, 22 Jan 2019 17:03:37

 

23andMe received FDA clearance to report on the two most common genetic variants influencing what is called MUTYH-associated polyposis (MAP), a hereditary colorectal cancer syndrome.This new clearance is part of…

The post 23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome appeared first on 23andMe Blog.


Discover more from

Subscribe to get the latest posts sent to your email.

3 thoughts on “23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome

Thanks for visiting my blog. I enjoy hearing your thoughts, and feedback. Have an awesome day.